ROLDENCLO
Celltrion, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79366726 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2023-03-06 | Application Filed |
| 2023-04-06 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2023-04-06 | Status: Live/Pending |
| 2023-04-07 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  CELLTRION, INC. |
| Address | 23, Academy-ro, Yeonsu-gu Incheon 22014 KR |
| Legal Entity Type | Corporation |
| Legal Entity State | KR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of bone loss; drugs for increasing bone density |
| GS0051 | Pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of bone loss; drugs, namely, pharmaceutical preparations for increasing bone density |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2023-04-06 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-04-07 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2023-04-11 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2023-12-04 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2023-12-05 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2023-12-06 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2023-12-13 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-12-13 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2024-01-02 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2024-01-24 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2024-01-24 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2024-01-25 | 12 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2024-01-31 | 13 CNSA O:Outgoing Correspondence |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2024-02-21 | 14 OP2R P: |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-02-21 | 15 NPUB E:E-Mail |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2024-02-21 | 16 NONP E:E-Mail |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2024-02-21 | 17 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2024-03-12 | 18 PUBO A:Allowance for Publication |
| NOTIFICATION PROCESSED BY IB | 2024-03-12 | 19 GPNX P: |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-03-12 | 20 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2024-05-28 | 21 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-05-28 | 22 NRCC E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 